These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
720 related articles for article (PubMed ID: 12566320)
21. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells. Han S; Inoue H; Flowers LC; Sidell N Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539 [TBL] [Abstract][Full Text] [Related]
22. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898 [TBL] [Abstract][Full Text] [Related]
23. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling. Dihlmann S; Siermann A; von Knebel Doeberitz M Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997 [TBL] [Abstract][Full Text] [Related]
24. Identification of Tcf-4 as a transcriptional target of p53 signalling. Rother K; Johne C; Spiesbach K; Haugwitz U; Tschöp K; Wasner M; Klein-Hitpass L; Möröy T; Mössner J; Engeland K Oncogene; 2004 Apr; 23(19):3376-84. PubMed ID: 14990988 [TBL] [Abstract][Full Text] [Related]
25. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers. Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341 [TBL] [Abstract][Full Text] [Related]
26. Isolation and characterization of a novel human gene, DRCTNNB1A, the expression of which is down-regulated by beta-catenin. Kawasoe T; Furukawa Y; Daigo Y; Nishiwaki T; Ishiguro H; Fujita M; Satoh S; Miwa N; Nagasawa Y; Miyoshi Y; Ogawa M; Nakamura Y Cancer Res; 2000 Jul; 60(13):3354-8. PubMed ID: 10910037 [TBL] [Abstract][Full Text] [Related]
27. Beta-catenin/Tcf activation partially mimics the transforming activity of Wnt-1 in Rat-1 fibroblasts. Young CS; Masckauchan TN; Kitajewski J Differentiation; 2003 Oct; 71(8):477-85. PubMed ID: 14641328 [TBL] [Abstract][Full Text] [Related]
28. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells. Davis JN; McCabe MT; Hayward SW; Park JM; Day ML Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358 [TBL] [Abstract][Full Text] [Related]
29. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745 [TBL] [Abstract][Full Text] [Related]
30. The role of cyclooxygenase-2 and prostaglandins in colon cancer. Eisinger AL; Prescott SM; Jones DA; Stafforini DM Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):147-54. PubMed ID: 17164142 [TBL] [Abstract][Full Text] [Related]
31. Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability. Fukushima H; Yamamoto H; Itoh F; Horiuchi S; Min Y; Iku S; Imai K J Exp Clin Cancer Res; 2001 Dec; 20(4):553-9. PubMed ID: 11876551 [TBL] [Abstract][Full Text] [Related]
32. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. Dong YF; Soung do Y; Schwarz EM; O'Keefe RJ; Drissi H J Cell Physiol; 2006 Jul; 208(1):77-86. PubMed ID: 16575901 [TBL] [Abstract][Full Text] [Related]
33. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138 [TBL] [Abstract][Full Text] [Related]
34. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc. Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729 [TBL] [Abstract][Full Text] [Related]
35. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours. Wong SC; Lo SF; Lee KC; Yam JW; Chan JK; Wendy Hsiao WL J Pathol; 2002 Feb; 196(2):145-53. PubMed ID: 11793365 [TBL] [Abstract][Full Text] [Related]
36. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors. Yan D; Wiesmann M; Rohan M; Chan V; Jefferson AB; Guo L; Sakamoto D; Caothien RH; Fuller JH; Reinhard C; Garcia PD; Randazzo FM; Escobedo J; Fantl WJ; Williams LT Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14973-8. PubMed ID: 11752446 [TBL] [Abstract][Full Text] [Related]
37. A comparative evaluation of beta-catenin and plakoglobin signaling activity. Williams BO; Barish GD; Klymkowsky MW; Varmus HE Oncogene; 2000 Nov; 19(50):5720-8. PubMed ID: 11126358 [TBL] [Abstract][Full Text] [Related]
38. The significance of the Wnt pathway in the pathology of human cancers. Karim R; Tse G; Putti T; Scolyer R; Lee S Pathology; 2004 Apr; 36(2):120-8. PubMed ID: 15203747 [TBL] [Abstract][Full Text] [Related]
39. Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas. Fujita M; Furukawa Y; Tsunoda T; Tanaka T; Ogawa M; Nakamura Y Cancer Res; 2001 Nov; 61(21):7722-6. PubMed ID: 11691783 [TBL] [Abstract][Full Text] [Related]
40. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402. Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]